MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by stealth21on May 19, 2009 2:10pm

211 Views

Post# 16001343

RE: patent info

Very strange indeed. Maybe they want it to fly under the radar. I saw this yesterday but I didn't look at the the date. Then this morning on stockhouse I saw one of our friends had noticed it, good job. I hope they have some valid reason for this. Probably we'll go up after the 28th, who knows. Who approval is around the corner. If MIR proves some sales, this thing could be very profitable in the near future.

Bullboard Posts

A Look into the Future of Chronic Pain Management